Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/13/2014 10/14/2014 10/15/2014 10/16/2014 10/17/2014 Date
162.77(c) 159.46(c) 160.73(c) 163.25(c) 164.75(c) Last
1 524 845 1 437 727 1 827 200 1 796 176 1 546 085 Volume
-3.00% -2.03% +0.80% +1.57% +0.92% Change
More quotes
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
10/23Earnings Release
Surperformance© rating of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 198 M
EBIT 2014 1 072 M
Net income 2014 709 M
Finance 2014 1 766 M
Yield 2014 -
Sales 2015 2 682 M
EBIT 2015 1 321 M
Net income 2015 930 M
Finance 2015 2 889 M
Yield 2015 -
PER 2014 48,75
PER 2015 35,45
EV / Sales 2014 14,0x
EV / Sales 2015 11,1x
Capitalization 32 590 M
More Financials
Latest news on ALEXION PHARMACEUTICALS, I
7h ago ALEXION PHARMACEUTICALS : Submits NDA for Asfotase Alfa
2d ago ALEXION PHARMACEUTICALS : to sponsor 2015 National Donor Memorial Award for Exce..
5d ago ALEXION PHARMACEUTICALS : to Report Third Quarter 2014 Results on Thursday, Octo..
5d ago ALEXION PHARMACEUTICALS : Submits NDA in Japan for Asfotase Alfa as a Treatment ..
7d ago NASDAQ 100 MOVERS : Tsla, vrtx
10/09 ALEXION PHARMACEUTICALS : to Report Third Quarter 2014 Results on Thursday, Octo..
10/09 ALEXION PHARMACEUTICALS : Change in Directors or Principal Officers, Financial S..
10/09 ALEXION PHARMACEUTICALS : Board of Directors Appoints New Chairman and Creates t..
10/07 ALEXION PHARMACEUTICALS : Change in Directors or Principal Officers, Financial S..
10/07 ALEXION PHARMACEUTICALS : Announces the Passing of Max Link, Ph.D., Chairman of ..
10/07DJALEXION PHARMACEUTICALS : Max Link, Board Chairman at Alexion and CytRx, Dies at..
10/03 ALEXION PHARMACEUTICALS : Patent Issued for Methods for Treating Chronic Lymphoc..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF